Gonadal dysfunction, specifically hypergonadotropic hypogonadism, in f
emale galactosemics is an almost universal finding. Minimal transferas
e activity may modulate ovarian function and the time of menopause. In
contrast, male galactosemics have a relatively low risk of gonadal dy
sfunction. Animal models have variously suggested prenatal and postnat
al insults which may play a role in the gonadal pathology. Several can
didate toxic states may be involved. Current dietary restrictions are
inadequate to prevent ovarian failure. Until such time as the pathophy
siology is better understood, therapy will remain palliative and suppo
rtive. Exogenous estrogen and progesterone have roles in assisting pub
ertal changes and in prevention of the sequelae of a post-menopausal s
tate.